Literature DB >> 22957310

Histone modifications and cancer: biomarkers of prognosis?

Yana Chervona1, Max Costa.   

Abstract

Epigenetic dysregulation is being increasingly recognized as a hallmark of cancer. Post-translational modifications of histones, in particular, are known to play important roles gene expression alterations in cancer development and progression. Given their key involvement in the various stages of carcinogenesis, histone modifications are also being explored as potential biomarkers of disease progression and prognosis. This review will therefore discuss the role of histone modifications in cancer biology and will explore their prognostic potential.

Entities:  

Keywords:  Histone modifications; biomarkers; cancer; prognosis

Year:  2012        PMID： 22957310      PMCID： PMC3433108     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN： 2156-6976            Impact factor:   6.166


  57 in total

Review 1.  Biomarkers in cancer staging, prognosis and treatment selection.

Authors:  Joseph A Ludwig; John N Weinstein
Journal:  Nat Rev Cancer       Date:  2005-11       Impact factor: 60.716

Review 2.  Dynamics and interplay of nuclear architecture, genome organization, and gene expression.

Authors:  Robert Schneider; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2007-12-01       Impact factor: 11.361

3.  Crystal structure of the nucleosome core particle at 2.8 A resolution.

Authors:  K Luger; A W Mäder; R K Richmond; D F Sargent; T J Richmond
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

4.  Global histone modification pattern associated with recurrence and disease-free survival in non-small cell lung cancer patients.

Authors:  Joon Seon Song; Yong Seok Kim; Dong Kwan Kim; Sung Il Park; Se Jin Jang
Journal:  Pathol Int       Date:  2012-01-31       Impact factor: 2.534

5.  Increased HDAC1 deposition at hematopoietic promoters in AML and its association with patient survival.

Authors:  Lara Tickenbrock; Hans-Ulrich Klein; Cristina Trento; Antje Hascher; Stefanie Göllner; Nicole Bäumer; Robert Kuss; Shuchi Agrawal; Gesine Bug; Hubert Serve; Christian Thiede; Gerhard Ehninger; Udo Zur Stadt; Michael McClelland; Yipeng Wang; Anke Becker; Steffen Koschmieder; Wolfgang E Berdel; Martin Dugas; Carsten Müller-Tidow
Journal:  Leuk Res       Date:  2010-12-22       Impact factor: 3.156

Review 6.  Histone modifications in cancer biology and prognosis.

Authors:  Siavash K Kurdistani
Journal:  Prog Drug Res       Date:  2011

7.  Global histone modification patterns predict risk of prostate cancer recurrence.

Authors:  David B Seligson; Steve Horvath; Tao Shi; Hong Yu; Sheila Tze; Michael Grunstein; Siavash K Kurdistani
Journal:  Nature       Date:  2005-06-30       Impact factor: 49.962

8.  Global levels of histone modifications predict prognosis in different cancers.

Authors:  David B Seligson; Steve Horvath; Matthew A McBrian; Vei Mah; Hong Yu; Sheila Tze; Qun Wang; David Chia; Lee Goodglick; Siavash K Kurdistani
Journal:  Am J Pathol       Date:  2009-04-06       Impact factor: 4.307

Review 9.  Histone modifications as markers of cancer prognosis: a cellular view.

Authors:  S K Kurdistani
Journal:  Br J Cancer       Date:  2007-06-26       Impact factor: 7.640

10.  Epigenomics: Pioneering a New Frontier in Cancer Research.

Authors:  Yana Chervona; Max Costa; Wei Dai
Journal:  J Pharmacogenomics Pharmacoproteomics       Date:  2012-01-23
View more
  69 in total

Review 1.  From genomes to societies: a holistic view of determinants of human health.

Authors:  Yuyan Shi; Sheng Zhong
Journal:  Curr Opin Biotechnol       Date:  2014-03-28       Impact factor: 9.740

Review 2.  Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.

Authors:  Sona Uramova; Peter Kubatka; Zuzana Dankova; Andrea Kapinova; Barbora Zolakova; Marek Samec; Pavol Zubor; Anthony Zulli; Vanda Valentova; Taeg Kyu Kwon; Peter Solar; Martin Kello; Karol Kajo; Dietrich Busselberg; Martin Pec; Jan Danko
Journal:  EPMA J       Date:  2018-11-12       Impact factor: 6.543

Review 3.  The Emerging Role of Non-traditional Ubiquitination in Oncogenic Pathways.

Authors:  Lisa Dwane; William M Gallagher; Tríona Ní Chonghaile; Darran P O'Connor
Journal:  J Biol Chem       Date:  2017-02-01       Impact factor: 5.157

4.  Endocrine resistant breast cancer cells with loss of ERα expression retain proliferative ability by reducing caspase7-mediated HDAC3 cleavage.

Authors:  Shiyi Yu; Xue Gong; Zhifang Ma; Meng Zhang; Ling Huang; Jun Zhang; Shuang Zhao; Tao Zhu; Zhenghong Yu; Liming Chen
Journal:  Cell Oncol (Dordr)       Date:  2019-11-07       Impact factor: 6.730

Review 5.  Epigenetic linkage of aging, cancer and nutrition.

Authors:  Michael Daniel; Trygve O Tollefsbol
Journal:  J Exp Biol       Date:  2015-01-01       Impact factor: 3.312

Review 6.  Anticancer potential of the histone deacetylase inhibitor-like effects of flavones, a subclass of polyphenolic compounds: a review.

Authors:  Prabhat Singh; Raghuvir Singh Tomar; Srikanta Kumar Rath
Journal:  Mol Biol Rep       Date:  2015-06-02       Impact factor: 2.316

7.  A time-series analysis of altered histone H3 acetylation and gene expression during the course of MMAIII-induced malignant transformation of urinary bladder cells.

Authors:  Jinqiu Zhu; Jie Wang; Xushen Chen; Maria Tsompana; Daniel Gaile; Michael Buck; Xuefeng Ren
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

8.  Aberrant expression of SETD1A promotes survival and migration of estrogen receptor α-positive breast cancer cells.

Authors:  Ming Li Jin; Young Woong Kim; Hong Lan Jin; Hoin Kang; Eun Kyung Lee; Michael R Stallcup; Kwang Won Jeong
Journal:  Int J Cancer       Date:  2018-10-04       Impact factor: 7.396

Review 9.  Epigenetic effects of green tea polyphenols in cancer.

Authors:  Susanne M Henning; Piwen Wang; Catherine L Carpenter; David Heber
Journal:  Epigenomics       Date:  2013-12       Impact factor: 4.778

10.  Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.

Authors:  Joyce V Lee; Alessandro Carrer; Supriya Shah; Nathaniel W Snyder; Shuanzeng Wei; Sriram Venneti; Andrew J Worth; Zuo-Fei Yuan; Hee-Woong Lim; Shichong Liu; Ellen Jackson; Nicole M Aiello; Naomi B Haas; Timothy R Rebbeck; Alexander Judkins; Kyoung-Jae Won; Lewis A Chodosh; Benjamin A Garcia; Ben Z Stanger; Michael D Feldman; Ian A Blair; Kathryn E Wellen
Journal:  Cell Metab       Date:  2014-07-03       Impact factor: 27.287
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.